The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global eye health supplements market is expected to exhibit a CAGR of 6.25% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Eye health supplements are fortified products consumed to help preserve the vision and maintain overall eye health. They contain nutrients that reduce the risk of cataracts, age-related macular degeneration (AMD) and other vision-disorders, which may further lead to partial or complete blindness. Moreover, vitamins are generally prescribed in combination with other essential nutrients to slow the progression of visual acuity loss and protect the cells from free radicals. Presently, there is a rise in the demand for eye health supplements across the globe as several research studies are showing that essential fatty acids are beneficial for proper visual and retinal function.
The continuous use of computers, tablets, and smartphones is increasing the risk of developing computer vision syndrome (CVS) and myopia. This represents one of the significant factors influencing the demand for eye health supplements worldwide. Moreover, the eyes produce fewer tears with age, which can further lead to AMD, cataracts, presbyopia, glaucoma, dry eyes, and temporal arteritis. The rising geriatric population, in confluence with the increasing awareness among individuals about the alternatives available for preventing different eye conditions, is also contributing to the market growth. Apart from this, governing agencies of numerous countries are supporting clinical studies to improve the understanding of nutrients on eye health. Additionally, several companies are entering strategic partnerships with healthcare businesses to expand their market share. This is anticipated to present lucrative opportunities to manufacturers and strengthen the market growth in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global eye health supplements market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on ingredient type, indication and formulation.
Breakup by Ingredient Type:
Breakup by Indication:
Breakup by Formulation:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alliance Pharma PLC, Amway International (Alticor), Bausch & Lomb Incorporated, Eyescience Labs, Kemin Industries Inc., Novartis AG, NutraChamps, Nutrivein, Pfizer Inc., The Nature's Bounty Co., Vitabiotics Ltd. and ZeaVision LLC.
|Base Year of the Analysis||2021|
|Segment Coverage||Ingredient Type, Indication, Formulation, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Alliance Pharma PLC, Amway International (Alticor), Bausch & Lomb Incorporated, Eyescience Labs, Kemin Industries Inc., Novartis AG, NutraChamps, Nutrivein, Pfizer Inc., The Nature's Bounty Co., Vitabiotics Ltd. and ZeaVision LLC|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at